← Home UAE · nd-uae

Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study

Source: en_prnasisa · 2026-10-14T07:30:00 UTC

AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 classification SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced findings from a study published in Nature Medicine, in which its AI-powered pathology platform, Lunit SCOPE, identified an asso

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study

Related in UAE

Dubai’s underground transport revolution: How the city will change

How this year’s Economics Nobel helps us understand the Gulf economies

I froze at the door: Syrian barber recalls surprise encounter with Cristiano Ronaldo

EU's new Lebanon security mission explained, and what's next

Bybit Revamps App to Reflect New Financial Platform Positioning, Unifying Crypto, Stocks, Macro Assets, Earn, and Alpha

Uzbekistan Hospitality Group TEG Completes U.S. Business Combination